Recently many potential protein biomarkers have been reported in the literature for the diagnosis of AML e.g. ApoE, complement factor H, HPT, apolipoprotein A-N, SAA1, and gelsolin using proteomics techniques28–31. This evidence concerns the gene APOE and acute myeloid leukemia.